已發(fā)表的部分文獻(xiàn): 標(biāo)題:Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.作者:Sipos A, Iv??n J, B??csi B, Darula Z, Tam??s I, Horv??th D, Medzihradszky KF, Erd?‘di F, Lontay B;雜志名稱:Sci Rep 標(biāo)題:SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.作者:Tamiya H, Kim H, Klymenko O, Kim H, Feng Y, Zhang T, Han JY, Murao A, Snipas SJ, Jilaveanu L, Brown K, Kluger H, Zhang H, Iwai K, Ronai ZA;雜志名稱:J Clin Invest 標(biāo)題:PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.作者:Snyder K, Zitzer NC, Gao Y, Choe HK, Sell NE, Neidemire-Colley L, Ignaci A, Kale C, Devine RD, Abad MG, Pietrzak M, Wang M, Lin H, Zhang YW, Behbehani GK, Jackman JE, Garzon R, Vaddi K, Baiocchi RA, Ranganathan P;雜志名稱:JCI Insight 標(biāo)題:Nitric Oxide Implication in Potato Immunity to <i>Phytophthora infestans</i> via Modifications of Histone H3/H4 Methylation Patterns on Defense Genes.作者:Drozda A, Kurpisz B, Arasimowicz-Jelonek M, Ku?onicki D, Jagodzik P, Guan Y, Floryszak-Wieczorek J;雜志名稱:Int J Mol Sci Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。